Global Investigation of Therapeutic Decisions in Hepatocellular Carcinoma and of its Treatment with Sorafenib (GIDEON) second interim analysis in more than 1,500 patients: Clinical findings in patients with liver dysfunction.
J. A. Marrero
Honoraria - Bayer; Onyx
Research Funding - Bayer
R. Lencioni
Honoraria - Bayer
M. Kudo
No relevant relationships to disclose
S. Ye
No relevant relationships to disclose
K. Nakajima
Employment or Leadership Position - Bayer
F. Cihon
Employment or Leadership Position - Bayer
A. P. Venook
Consultant or Advisory Role - Abbott Laboratories (U); Bristol-Myers Squibb (U); Chugai Pharma (U)
Research Funding - Bayer